TLDR – TDR News –  March 18th to 19th 

Get a quick update on today’s TDR News! We’ve condensed the most important information about Cannabis, Psychedelics, Crypto and Miners, AI, Small Cap REITS and Large $$ Volume Mega Caps into a brief format, saving you time and keeping you informed as you start your day. 

Recap of Monday

The TDR Comprehensive Cannabis Index increased by more than 5% on Monday, while the TDR Retail Cannabis Index rose by nearly 8.5%. All other indexes showed gains except for the TDR Crypto Index, which was down 4% on the day.

What’s Driving the Market Today?

The futures are up and showing a little green, here is what is in focus globally for stocks:

  • BOJ ends negative rates, yen at 34-year lows
  • AI buzz lifts Alphabet, Nvidia
  • Australia holds rates, confident on inflation
  • Dollar rises, Fed meeting eyed
  • Tesla up 6%, boosts S&P 500

Cannabis Capital Market News:

The High Flyers yesterday were led by CordovaCanna which was up by just over 33%, and the Low Flyers were led by Statehouse, which was down over 17% on the day. Here are the charts of the High and Low Flyers:

Let’s examine the highlights from companies in the TDR Comprehensive Cannabis Index!

  1. TDR Research releases a ‘Buy’ rating for Tilray Brands (TSX: TLRY, NASDAQ: TLRY) with a detailed analysis on its financial performance and one year  target price of $3.28. Yesterday we  launched research on Auxly Cannabis and it is available for free for our Newsletter Subscribers.
  2. LEEF (CSE: LEEF, OTC: LEEEF) launches Well-Kept CBD Infused Honey, integrating bee farming for environmental and wellness innovation.

Cannabis News 

  1. Gov. Hochul orders a review of New York’s cannabis licensing amid slow legal shop openings and rampant illegal stores. Read all about it on the TDR Website!
  2. The majority of Canadians prefer legal cannabis for its safety and convenience, marking a significant shift in consumer behavior. Read all about it on the TDR Website!

Cannabis Policy Highlights from our Friends at Marijuana Moment:

  1. Vice President Harris privately declared “we need to legalize marijuana” during a White House meeting on cannabis clemency.
  2. A Colorado bill aims to require social media platforms to ban users promoting marijuana, psychedelics, and certain hemp products.
  3. Recent incidents highlight the conflict between federal firearms restrictions and marijuana users, raising constitutional questions and calls for reform.

Psychedelic News:

  1. Silo Pharma (Nasdaq: SILO) files for a patent on SP-26, a ketamine implant for fibromyalgia and chronic pain management.
  2. The Maryland Senate approved a bill to form a task force studying the regulatory framework for psilocybin and DMT access.
  3. Vermont Senate panel revises a psilocybin bill to focus on studying psychedelic-assisted therapy instead of legalization.

Crypto and Crypto Miners:

  1. Standard Chartered predicts Bitcoin will surge to $150k by the end of 2024, citing spot ETF inflows and the upcoming halving event.
  2. Binance’s user asset holdings have surpassed $100 billion, bolstered by rising digital asset prices and strong inflows.
  3. The IMF requires Pakistan to tax crypto profits to secure a $3 billion bailout, amid negotiations involving broader tax measures.
  4. Marathon (NASDAQ: MARA) boosts its Bitcoin mining operations with a renewable energy-focused, strategic acquisition in Texas. Read all about it on the TDR Website!


  1. Goldman Sachs‘ Chief Economist Jan Hatzius believes AI could benefit the US economy despite job destruction concerns.
  2. Elon Musk’s xAI has open-sourced its Grok large language model, allowing free access and modification under Apache 2.0 license.

Big $ Volume Big Caps Highlights:

  1. Nvidia (Nasdaq: NVDA) introduces Blackwell, a faster AI processor with 208 billion transistors, set to power major data centers.

Want to keep up to date with all of TDR’s research and news, subscribe to our daily Baked In newsletter.   

You might also like

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More